This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

WhiteHawk Minerals Corp Class A
ERock, Inc. Class A
Wise Group plc Class A
Forbright, Inc. Class A
Parabilis Medicines, Inc.

WhiteHawk Minerals Corp Class A

WHK

0.00

ERock, Inc. Class A

EROC

0.00

Wise Group plc Class A

WSE

0.00

Forbright, Inc. Class A

FRBT

0.00

Parabilis Medicines, Inc.

PBLS

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Evercore ISI Group analyst Nicholas Amicucci initiated coverage on ERock (NYSE:EROC) with an Outperform rating and announced a price target of $28. ERock shares closed at $15.47 on Thursday. See how other analysts view this stock.
  • JP Morgan analyst Craig McDowell initiated coverage on Wise Group PLC (NASDAQ:WSE) with an Overweight rating and announced a price target of $17.5. Wise Group shares closed at $12.95 on Thursday. See how other analysts view this stock.
  • Goldman Sachs analyst Sahar Islam initiated coverage on Forbright (NASDAQ:FRBT) with a Buy rating and announced a price target of $23.5. Forbright shares closed at $18.75 on Thursday. See how other analysts view this stock.
  • B of A Securities analyst Tazeen Ahmad initiated coverage on Parabilis Medicines (NASDAQ:PBLS) with a Buy rating and announced a price target of $45. Parabilis Medicines shares closed at $29.58 on Thursday. See how other analysts view this stock.
  • Stifel analyst Selman Akyol initiated coverage on Whitehawk Minerals Corp (NYSE:WHK) with a Buy rating and announced a price target of $30. WhiteHawk Minerals shares closed at $27.37 on Thursday. See how other analysts view this stock.

Considering buying PBLS stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.